Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(33.3%)
Phase 1
1(33.3%)
N/A
1(33.3%)
3Total
Phase 3(1)
Phase 1(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT00979784Not ApplicableCompleted

Better Weight-Better Sleep (BWBS) Trial

Role: collaborator

NCT00243984Phase 3Suspended

Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome

Role: lead

NCT00258492Phase 1Unknown

Restless Legs Syndrome Exercise Intervention

Role: lead

All 3 trials loaded